Citation tools
"Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).." The Journal of Rheumatology
30.12
(2003):
2563-2571.
Web. 05 Dec. 2023.